Helios and Matheson Analytics Inc (NASDAQ:HMNY) and MoviePass™ reported that MoviePass™ is providing a 1 year subscription plan for $89.95, including a processing fee of $6.55. Existing MoviePass consumers will get 25% savings from their prevailing $9.95 per month plan in case they subscribe to the new subscription plan. The one-year subscription plan is offered only for a limited time, offering movie-lovers a chance to attend the films they want at a lower price for a year.
MoviePass™ introduced its subscription plan worth $9.95 per month in August 2017, after a notable investment from Helios. The investment has allowed MoviePass™ to offer on its objective to bring considerable innovation to the movie theater segment and drive improved attendance to lower-budget films and movie theaters. Existing and new subscribers of MoviePass™ who take benefit of the new 1-year subscription plan will be charged $89.95 for the year in advance when they subscribe to the company’s plan.
Mitch Lowe, the CEO of MoviePass, expressed that this limited time offer is remarkable for movie-fans. At this price, it’s tough to compare it to anything else that offers as much entertainment for a year. They are venturing into the prime film going season, so now marks the perfect time to take benefit of the MoviePass™ movement.
Ted Farnsworth, the CEO and Chairman of HMNY, expressed that Helios and Matheson continues to be the leading supporter of MoviePass™, as it surpasses any other film theater subscription service and persists to disrupt the respective industry. They expect to helping MoviePass™ broadens its reach and streamline the movie theater industry.
In the last trading session, the stock price of Helios and Matheson declined more than 21% to close the day at $9.50. The decline came at a share volume of 6.55 million compared to average share volume of 5.20 million.
DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of financialstrend.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: